COVID-19 vaccine: UK medicine regulator to assess best dose regimen of Oxford-AstraZeneca vaccine

By: |
December 9, 2020 3:47 PM

"The position is we will look at every piece of evidence... part of that will be to examine with great rigour, the basis for the appropriate dosage regimen."

The first batch of Oxford Covishield vaccine containing 2.64 lakh doses had reached the Delhi's central storage facility at Rajiv Gandhi Super Speciality Hospital on Tuesday.

Britain’s medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator’s chief executive said on Wednesday.

“Our regulatory review is all encompassing. We will look at all available data,” June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), told lawmakers after a study showed the vaccine had efficacy of 62% for trial participants given two full doses, but 90% for a smaller sub-group given a half, then a full dose.

“Clearly, we have great interest into the possible reasons for the different doses having a different efficacy… readout,” she said.

“The position is we will look at every piece of evidence… part of that will be to examine with great rigour, the basis for the appropriate dosage regimen.”

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 vaccination in India: Over 20 lakh beneficiaries inoculated
2Covid-19 vaccine update: EU demands that vaccine makers honour their commitments
3COVID-19 in Delhi: 157 fresh cases, positivity rate slips to 0.24%